Researchers show Joe Rogan’s principle about 20-cent surprise drug taken by thousands and thousands of Individuals is right… as colon most cancers hyperlink emerges

An affordable drug usually promoted by podcaster and health fanatic Joe Rogan might decrease the danger of colon most cancers.

A brand new examine discovered metformin – a 20-cent capsule used to handle kind 2 diabetes – reduce the danger of creating the lethal illness by as much as 13 %.

Israeli researchers tracked 31,000 who took metformin for as much as 5 years. 

In the long run, sufferers who took the drug for 3 to 5 years had a 13 % decrease danger of creating colon most cancers within the a part of the colon most inclined to tumors. Taking the drug for one to 3 years was related to a ten % decline in danger.

Contributors have been from the Veterans Affairs database, and most have been over 50 years outdated, however researchers mentioned their outcomes urged metformin might doubtlessly be used to assist forestall colon most cancers for wider teams.

Uncontrolled diabetes is a danger issue for the illness, so treating it generally could decrease most cancers danger, however utilizing metformin could present extra advantages, as earlier analysis has proven the drug has been linked to slowed ageing and diminished mortality.

Well-liked podcaster Joe Rogan, 57, who hasn’t revealed if he’s taking the drug himself, usually talks concerning the medicine on his podcast, with professional company touting its potential longevity advantages.  

One visitor, Harvard anti-aging scientist Dr David Sinclair claimed it might assist to sluggish ageing – and in an interview with Dr Sinclair in 2019, Rogan mentioned: ‘I obtained to discover a quack that is keen to prescribe me metformin.’

A examine means that metformin, which Joe Rogan has talked about repeatedly on his fashionable podcast, might assist to cut back the danger of colon most cancers on the left aspect of the colon

Metformin has been permitted for kind 2 diabetics however is prescribed off label for a spread of illnesses. Researchers are additionally taking a look at whether or not it might be used to combat ageing

The examine was revealed at ASCO 2025, the world’s largest most cancers convention happening this week in Chicago, Illinois.

Whereas promising, scientists behind the paper didn’t present an evidence as to why the drug could also be protecting and mentioned their outcomes wanted to be confirmed with extra analysis.

Metformin is a prescription-only medicine permitted for kind 2 diabetics to assist them management blood sugar ranges, with sufferers taking about two drugs per day – generally priced at as little as 20 cents a capsule. It’s estimated that over 19 million Individuals are prescribed it every year.

However it’s also prescribed off-label for plenty of different circumstances, together with prediabetes and Polycystic Ovary Syndrome, a situation during which ladies expertise cysts on their ovaries.

Scientists from The Jusidman Most cancers Middle in Israel analyzed information on sufferers within the Veterans Affairs database from 1999 to 2020.

They recruited sufferers on metformin and matched them to sufferers with related traits not on metformin. 

These tended to be much less wholesome sufferers, which raises the danger of a colon most cancers analysis or comorbidity.

Within the metformin group, the vast majority of sufferers had used the substance for at the very least 5 years.

General, information was out there on the situation of the tumor for greater than 113,000 sufferers within the examine.

Of those, 13,691 have been within the metformin group – together with 9,588 (70 %) who developed colon most cancers on the left aspect of the colon.

Roughly 100,000 folks have been within the non-metformin group – together with 95,000 (95 %) who developed the most cancers on the left aspect of their colon. 

Colon most cancers is more and more placing younger folks. Bailey Hutchins of Tennessee (pictured), died of colon most cancers at 26 years outdated

The researchers work was revealed as an summary by the American Society of Scientific Oncology and has not been made totally out there or peer reviewed. 

Nevertheless, beforehand revealed work has discovered related advantages.

A examine from 2019 discovered metformin was related to an eight % discount in colorectal most cancers. By location, it was related to a 14 % discount within the danger of most cancers within the rectum. 

A 2024 examine regarded on the expression of HCT116 cells – these present in colon most cancers sufferers. When these cells develop abnormally, it contributes to tumor development, however metformin altered the expression of those cells.

Outcomes confirmed the medicine upregulated genes that will suppress the expansion and unfold of colorectal most cancers cells. 

One other 2024 examine discovered metformin use was related to ‘considerably decrease’ colon most cancers danger in each the colon and rectum – a few 30 % decline in danger.  

And an elevated protecting impact was noticed in white folks and people with weight problems. 

Researchers concluded metformin’s advantages ‘doubtless generalizes to populations with increased underlying danger.’